A recent study applied machine learning to investigate which physicochemical and experimental factors were most involved in genotoxicity of titanium dioxide (TiO2). The findings confirmed that exposure concentration, cell medium composition, and lysis temperature in the comet assay correlate with DNA damage. The identified correlations could provide valuable insights for standardizing this test. However, the study methods and findings are too limited to identify new parameters involved in genotoxicity. Also, the scope was not aimed at providing evidence on the genotoxicity of TiO2, and therefore the study has no direct relevance for the discussion on the carcinogenicity classification of TiO2 nanomaterials.

A recent review discusses the suitability of in vitro models for studying the intestinal uptake of nanomaterials. While Caco-2 cell models are widely recognised for studying chemical uptake, their suitability for nanomaterials is limited due to the complex physiological processes involved, prompting the need for more advanced co-culture models. Significant knowledge gaps remain, especially in standardising and assessing how well these models mimic human biology and relevant exposure scenarios. Currently, the first steps towards harmonization of new approach methodologies as a tool to predict intestinal uptake of nanomaterials are being taken.

Advancements in nanoscience over the past 25 years have significantly influenced fields like nanoelectronics, bionanotechnology, and nanophotonics, driving innovations in computing, healthcare, and energy. Two key publications celebrate these achievements while underscoring the necessity for robust safety governance frameworks to address health, environmental, and ethical concerns associated with nanomaterials. As the integration of nanotechnology into everyday life accelerates, understanding the risks and benefits of these materials becomes crucial, prompting a call for proactive, adaptive regulatory approaches and international collaboration.

A recent review highlights the potential of using common waste materials, such as fruit peels and food waste, for the sustainable synthesis of nanoparticles, utilizing their rich natural compounds as reducing and stabilizing agents. This green chemistry approach enhances production efficiency compared to traditional methods, offering significant economic and environmental benefits by using biomass waste streams and reducing raw material costs. Challenges remain regarding consistency, long-term safety, and scaling up production. There is a need for clear regulatory guidelines and standardised toxico¬logical evaluations which are improved to enable wider industrial adoption.

MXenes (pronounced maxenes) are a unique family of two-dimensional materials. Current regulatory frameworks struggle to effectively manage MXenes due to their distinct properties and lack of appropriate safety testing methods. The OECD's Early4AdMa methodology highlights the need for improved characterisation, toxicity testing, and greener production processes for titanium carbide MXenes, emphasising the limited data available on their health and environmental impacts. Proactive regulation and interdisciplinary collaboration are essential as MXenes move closer to commercialisation, ensuring that safety and sustainability considerations are incorporated into the development of advanced materials.

The U.S. National Nanotechnology Initiative has updated its Environmental Health and Safety strategy to address ongoing challenges and emerging nanotechnology applications. The strategy emphasises responsible innovation and highlights the need for collaborative actions to address concerns related to the impact of engineered nanomaterials on human health and the environment.

Scientists from the public, private and philanthropic sectors involved in the Nano4EARTH initiative have identified key research directions to maximise the impact of nanotechnology in addressing climate change. They focus on enhancing energy storage, reducing industrial carbon emissions and improving efficiency in industrial processes.

Lipid nanoparticles (LNPs) are a groundbreaking delivery system for mRNA vaccines, such as those used for COVID-19. Now, they are pivotal in developing a range of new vaccines and gene therapies. The European Medicines Agency (EMA) and the European Pharmacopoeia are actively updating guidelines and quality requirements to ensure the safe and effective use of LNP-based medicine.

A recent EU ON opinion highlights the potential of advanced materials to support sustainability goals while acknowledging their human health and environmental risks. The European Commission’s 2024 communication emphasises the need for Safe-and-Sustainable-by-Design (SSbD) principles to ensure safety and sustainability.

The degradation of two-dimensional (2D) materials throughout their life cycle can result in the formation of degradation products with different properties and effects on human health and the environment than the original materials.